Detalhe da pesquisa
1.
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Hepatol Res
; 54(4): 326-335, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37975277
2.
Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
Hepatol Res
; 54(2): 201-212, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37796562
3.
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
Hepatol Res
; 53(5): 383-390, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36826411
4.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36149726
5.
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.
Int J Mol Sci
; 24(18)2023 Sep 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37762018
6.
Treatment and the prognosis of hepatocellular carcinoma in Asia.
Liver Int
; 42(9): 2042-2054, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34894051
7.
MAFLD: Renovation of clinical practice and disease awareness of fatty liver.
Hepatol Res
; 52(5): 422-432, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34472683
8.
Lean/normal-weight metabolic dysfunction-associated fatty liver disease is a risk factor for reflux esophagitis.
Hepatol Res
; 52(8): 699-711, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35585481
9.
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.
J Gastroenterol Hepatol
; 37(3): 592-599, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34928509
10.
Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis.
Medicina (Kaunas)
; 58(8)2022 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36013545
11.
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
Semin Liver Dis
; 41(3): 225-234, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34147036
12.
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
Oncology
; 99(12): 756-765, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34518483
13.
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
Liver Int
; 41(6): 1389-1397, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33547848
14.
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 41(12): 2997-3008, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34250737
15.
Association between the albumin-bilirubin (ALBI) score and severity of portopulmonary hypertension (PoPH): A data-mining analysis.
Hepatol Res
; 51(12): 1207-1218, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34534392
16.
Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures.
Hepatol Res
; 51(12): 1181-1195, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34555262
17.
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach.
Hepatol Res
; 51(11): 1115-1128, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34129272
18.
Effects of a low-intensity resistance exercise program on serum miR-630, miR-5703, and Fractalkine/CX3CL1 expressions in subjects with No exercise habits: A preliminary study.
Hepatol Res
; 51(7): 823-833, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34014020
19.
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study.
Hepatol Res
; 51(12): 1229-1241, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34591334
20.
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
J Gastroenterol Hepatol
; 36(3): 629-636, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32627871